| Abdominal Regional Perfusion in Donation After Cardiac Death for Multi-Organ Transplantation (NCT03946852) | London Health Sciences Centre | 2019-06-01 |
| Study of ET140202 T Cells in Adults With Advanced Hepatocellular Carcinoma (NCT03998033) | Eureka Therapeutics Inc. | 2019-05-30 |
| ET 140202 -T Cell Combined With TAE or Sorafenib in the Treatment of Liver Cancer (NCT03965546) | First Affiliated Hospital Xi'an Jiaotong University | 2019-05-30 |
| DIAbetes and NAFLD (NCT06315361) | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2019-05-20 |
| Stereotactic Body Radiation Therapy (SBRT) Efficiency and Toxicity in Liver Cancer (NCT03408665) | Centre Oscar Lambret | 2019-03-13 |
| The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study (NCT04075305) | UMC Utrecht | 2019-02-01 |
| Clinical Trial of Cinobufacini Combined With Transarterial Chemoembolization (TACE) on Primary Liver Cancer (NCT03843229) | The First Affiliated Hospital of Dalian Medical University | 2019-01-27 |
| Association Between Autologous Transfusion and Recurrence-free Survival in Patients With HCC After Resection (NCT02654028) | Guangxi Medical University | 2019-01-05 |
| Infusion of PD1/PDL1/CTLA4 Inhibitors Via Hepatic Arterial for Immunotherapy of Hepatocellular Carcinoma (NCT03949231) | Second Affiliated Hospital of Guangzhou Medical University | 2019-01-01 |
| Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Patients With Pediatric Solid Tumors (GAP) (NCT02932956) | Baylor College of Medicine | 2018-12-17 |
| PAN-study: Pan-Cancer Early Detection Study (PAN) (NCT03756597) | Owlstone Ltd | 2018-09-26 |
| Prospective Cohort Study of Liver Cancer Patients Treated With Proton Beam Therapy (NCT04466124) | National Cancer Center, Korea | 2018-09-21 |
| Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors (NCT03662204) | Exact Sciences Corporation | 2018-08-23 |
| QUILT-2.025 NANT Neoepitope Yeast Vaccine (YE-NEO-001): Adjuvant Immunotherapy Using a Personalized Neoepitope Yeast-Based Vaccine To Induce T-Cell Responses In Subjects W/ Previously Treated Cancers. (NCT03552718) | NantBioScience, Inc. | 2018-08-10 |
| Tampa Associating Microwave Liver Ablation With Portal Vein Ligation for Staged Hepatectomy (TAMLAPS) (NCT03739164) | Florida Hospital Tampa Bay Division | 2018-07-18 |
| The Impact of Fast-track Perioperative Program After Liver Resection in Hong Kong Chinese Patients (NCT03223818) | Chinese University of Hong Kong | 2018-07-01 |
| Xenotransplantation of Primary Cancer Samples in Zebrafish Embryos (NCT03668418) | University of Pisa | 2018-06-01 |
| Personal Resilience Empowerment Program Study (NCT03644173) | Hackensack Meridian Health | 2018-05-30 |
| Feasibility of Online MR-guided Radiotherapy on a 1.5T MR-Linac (NCT04172753) | University Hospital Tuebingen | 2018-05-09 |
| Accuracy of the LiverVision® Semi-automated Liver Volumetry Software (NCT03766633) | Royal Free Hospital NHS Foundation Trust | 2018-04-29 |
| Gadolinium Contrast-enhanced Abbreviated MRI (AMRI) vs. Standard Ultrasound for Hepatocellular Carcinoma (HCC) Surveillance in Patients With Cirrhosis (NCT04288323) | University of California, San Diego | 2018-04-27 |
| Standardized CEUS Algorithms for Diagnosis of HCC - Prospective German Multicenter Study (NCT03405909) | University Hospital Erlangen | 2018-04-21 |
| A Study of Nivolumab in Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or Ablation (NCT03383458) | Bristol-Myers Squibb | 2018-04-18 |
| The Intention-to-treat Effect of Bridge Therapies in the Setting of Milan-in Patients (NCT03723304) | European Hepatocellular Cancer Liver Transplant Group | 2018-03-01 |
| Effectiveness of Positioning on Back Pain After TACE Among Patients With HCC (NCT03784469) | National Taiwan University Hospital | 2018-02-21 |
| Trajectory-Based Prognostic Modeling in Hepatocellular Carcinoma (NCT07204262) | Xu Yong, MD | 2018-01-01 |
| Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory Solid Tumor Malignancies (NCT03199586) | Novita Pharmaceuticals, Inc. | 2017-12-21 |
| ET1402L1-ARTEMIS™2 T Cells in Alpha Fetoprotein (AFP) Expressing Hepatocellular Carcinoma (NCT03888859) | First Affiliated Hospital Xi'an Jiaotong University | 2017-12-06 |
| High Dose Rate Brachyablation of Primary Liver Lesions (NCT02893982) | University of Texas Southwestern Medical Center | 2017-11-09 |
| Clinical Study of ET1402L1-CAR T Cells in AFP Expressing Hepatocellular Carcinoma (NCT03349255) | Aeon Therapeutics (Shanghai) Co., Ltd. | 2017-10-06 |
| Nursing Fro Laparoscopic vs. Open Hepatectomy (NCT03585166) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2017-10-01 |
| Novel Molecular Spectrometric Biomarkers in Blood Plasma as an Early Diagnostic Tool in HCC (NCT04221347) | Military University Hospital, Prague | 2017-10-01 |
| Liver Regeneration (NCT03396705) | University Health Network, Toronto | 2017-09-12 |
| HepaT1ca: Quantifying Liver Health in Surgical Candidates for Liver Malignancies (NCT03213314) | University of Edinburgh | 2017-09-07 |
| A Study to Assess the Effect of Y-90 Therapy on Non-target/Background Liver (NCT02966223) | Indiana University | 2017-08-17 |
| CIRSE Registry for SIR-Spheres in France (CIRT-FR) (NCT03256994) | Cardiovascular and Interventional Radiological Society of Europe | 2017-08-01 |
| Volatiles in Breath and Headspace Analysis - Diagnostic Markers (NCT03228095) | University of Latvia | 2017-07-24 |
| Mechanically-assisted Ventilation in the Treatment of Moving Tumours With Photon and Proton Therapies (NCT03226925) | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 2017-06-30 |
| Safety and Efficiency of γδ T Cell Against Liver Cancer (NCT03183219) | Fuda Cancer Hospital, Guangzhou | 2017-06-15 |
| Pembrolizumab, a Monoclonal Antibody Against PD-1, in Combination With Capecitabine and Oxaliplatin (CAPOX) in People With Advanced Biliary Tract Carcinoma (BTC) (NCT03111732) | National Cancer Institute (NCI) | 2017-06-14 |
| A Pilot Study to Assess Theragnostically Planned Liver Radiation to Optimize Radiation Therapy (NCT03338062) | Indiana University | 2017-06-13 |
| Celebrex and Metformin for Postoperative Hepatocellular Carcinoma (NCT03184493) | Guangxi Medical University | 2017-06-02 |
| The Role of 5% Lidocaine Patches in the Pain Control of Hepatocellular Carcinoma Patients Receiving Radiofrequency Ablation (NCT05732181) | National Cheng-Kung University Hospital | 2017-05-09 |
| A Study to Test the Safety and Feasibility of Nivolumab With Drug Eluting Bead Transarterial Chemoembolization in Patients With Liver Cancer (NCT03143270) | Memorial Sloan Kettering Cancer Center | 2017-04-28 |
| Sorafenib and Bavituximab Plus SBRT in Unresectable Hepatocellular Carcinoma (NCT02989870) | H. Lee Moffitt Cancer Center and Research Institute | 2017-03-27 |
| Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil/Leucovorin Versus Sorafenib in Advanced Hepatocellular Carcinoma (NCT03164382) | Sun Yat-sen University | 2017-03-01 |
| Improving Outcomes in Cancer Patients With a Nutritional and Physical Conditioning Prehabilitation Program (NCT03475966) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2017-02-22 |
| A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6 (NCT03058289) | Intensity Therapeutics, Inc. | 2017-02-09 |
| Biobank for Cholestatic Liver Diseases. (NCT03445585) | Mayo Clinic | 2017-01-01 |
| Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of H3B-6527 in Participants With Advanced Hepatocellular Carcinoma (NCT02834780) | H3 Biomedicine Inc. | 2016-12-28 |
| A Worldwide Score for Hepatocellular Cancer and Liver Transplantation (NCT03595345) | European Hepatocellular Cancer Liver Transplant Group | 2016-12-15 |
| Impact of Preoperative Sarcopenia on Morbidity and Mortality in Patients Operated on From Digestive Cancers (NCT02811666) | CHU de Reims | 2016-11-01 |
| Study of TBI-1301 (NY-ESO-1 Specific TCR Gene Transduced Autologous T Lymphocytes) in Patients With Solid Tumors (NCT02869217) | University Health Network, Toronto | 2016-09-01 |
| Parecoxib Versus Celecoxib Versus Oxycodone in Pain Control for Transcatheter Chemoembolization Procedure (NCT03059238) | Sun Yat-sen University | 2016-09-01 |
| Programs To Support You During Chemotherapy (NCT02489422) | Wake Forest University Health Sciences | 2016-08-01 |
| Factors Influencing the 3-Year Recurrence of Liver Carcinoma After Surgery (NCT02941861) | Ruechuta Molek | 2016-08-01 |
| MLN0128 Compared to Sorafenib in Advanced or Metastatic Hepatocellular Carcinoma (NCT02575339) | Kathy Miller | 2016-07-18 |
| A Pilot Study of Combined Immune Checkpoint Inhibition in Combination With Ablative Therapies in Subjects With Hepatocellular Carcinoma (HCC) or Biliary Tract Carcinomas (BTC) (NCT02821754) | National Cancer Institute (NCI) | 2016-07-05 |
| Effect of Surefire Infusion Device on Tumor Response to Regional Intra-arterial Therapy for Primary Liver Malignancies (NCT02853500) | Dana-Farber Cancer Institute | 2016-07-01 |
| Microwave Ablation for the Treatment of Malignant Liver Tumors Closed to Intrahepatic Vessels (NCT03063840) | National Taiwan University Hospital | 2016-07-01 |
| Intra-luminal Radiofrequency Ablation for Inoperable Malignant Biliary Stenosis (NCT02841800) | National Taiwan University Hospital | 2016-06-01 |
| Ultrasound Monitoring of Abdominal Soft Tissue (NCT02722616) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2016-05-01 |
| A Study to See if we Can Predict How Your Liver Tumor or Liver Metastases Will Respond to Trans-Arterial Embolization (TAE) (NCT02772575) | Memorial Sloan Kettering Cancer Center | 2016-04-01 |
| First-in-Human Safety, Tolerability and Antitumour Activity Study of MTL-CEBPA in Patients With Advanced Liver Cancer (NCT02716012) | Mina Alpha Limited | 2016-03-01 |
| T Cell Mediated Adaptive Therapy for Her2-positive Neoplasms of Digestive System (NCT02662348) | Yi Miao | 2016-02-01 |
| NBTXR3 Crystalline Nanoparticles and Stereotactic Body Radiation Therapy in the Treatment of Liver Cancers (NCT02721056) | Nanobiotix | 2016-01-28 |
| LC Bead LUMI Radio-Opaque Embolic Beads to Detect and Characterize the Vascularity of Hepatic Tumors (NCT02649868) | National Institutes of Health Clinical Center (CC) | 2016-01-12 |
| Study of Liver Resection With Versus Without Hepatic Inflow Occlusion for the HBV-related HCC (NCT02563158) | Chinese PLA General Hospital | 2016-01-01 |
| Resveratrol and Human Hepatocyte Function in Cancer (NCT02261844) | University of Louisville | 2015-12-01 |
| DEB-TACE Treatment in 367 Liver Cancer Patients (NCT03317483) | Zhejiang Cancer Hospital | 2015-11-12 |
| Gut Microbiota in People With Hepatocellular Carcinoma (HCC) (NCT02599909) | National Cancer Institute (NCI) | 2015-11-06 |
| Pharmacokinetics of Doxorubicin in cTACE of Liver Cancer (NCT02753881) | Yale University | 2015-11-01 |
| Evaluation of Cytokine-induced Killer (CIK) Cells as Therapy or Adjuvant Treatment for Advanced HCC (NCT02568748) | Sherief Abd-Elsalam | 2015-10-01 |
| Radical Surgery Followed by Immunotherapy Using Precision T Cells Specific to Multiple Common Tumor-Associated Antigen for the Treatment of Hepatocellular Carcinoma (NCT02632188) | Second Military Medical University | 2015-09-01 |
| Patient Controlled Epidural Analgesia Versus Intravenous Patient Controlled Analgesia for Post-Operative Pain Control in Patients Undergoing Elective Liver Resection (NCT02523443) | Memorial Sloan Kettering Cancer Center | 2015-08-01 |
| Liver Cancer HepaSphere Combined With Cryosurgery (NCT02545556) | Fuda Cancer Hospital, Guangzhou | 2015-08-01 |
| Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers (NCT02349412) | Alliance for Clinical Trials in Oncology | 2015-06-25 |
| Integrated Imaging Strategy to Phenotype Progression of Liver Tumors During and After Chemoembolization (NCT02471313) | National Institutes of Health Clinical Center (CC) | 2015-06-12 |
| Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART133 (NCT02541370) | Chinese PLA General Hospital | 2015-06-01 |
| Nano Drug Interventional Therapy Using Digital Subtraction Angiography（DSA） for Liver Carcinoma (NCT02449109) | Fuda Cancer Hospital, Guangzhou | 2015-05-01 |
| Pillars4Life Trial (NCT02465892) | Duke University | 2015-05-01 |
| Survivorship Promotion In Reducing IGF-1 Trial (NCT02431676) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2015-05-01 |
| HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA） for Liver Cancer (NCT02447263) | Fuda Cancer Hospital, Guangzhou | 2015-05-01 |
| Safety and Efficiency of γδ T Cell Against Hepatocellular Liver Cancer (NCT02425735) | Fuda Cancer Hospital, Guangzhou | 2015-04-01 |
| Trametinib in Combination With Sorafenib in Patients With Advanced Hepatocellular Cancer (NCT02292173) | H. Lee Moffitt Cancer Center and Research Institute | 2015-02-18 |
| The Role of the Vitamin D Receptor Gene Polymorphisms in Hepatocarcinogenesis (NCT02461979) | Sherief Abd-Elsalam | 2015-02-01 |
| Chemoembolisation of Hepatocellular Carcinomas Not Subject to Interventive Care by Idarubicin-loaded Beads - IDASPHERE II (NCT02185768) | Federation Francophone de Cancerologie Digestive | 2015-01-01 |
| Irreversible Electroporation(IRE) For Unresectable Portal Venous Tumor Emboli (NCT02333773) | Fuda Cancer Hospital, Guangzhou | 2015-01-01 |
| SBRT for Liver Cancer Before Liver Transplantation (NCT04186234) | The University of Hong Kong | 2015-01-01 |
| Liver Cancer Immunotherapy: Placebo-controlled Clinical Trial of Hepcortespenlisimut-L (NCT02232490) | Immunitor LLC | 2015-01-01 |
| Adaptive MRI-Guided SBRT for Unresectable Primary or Oligometastatic Central Thorax and Abdominal Malignancies (NCT02264886) | Washington University School of Medicine | 2015-01-01 |
| Single Session Combined Locoregional Therapies for Hepatocellular Carcinoma (NCT02646137) | Sherief Abd-Elsalam | 2015-01-01 |
| Vitamin B-6 and Glutathione on Inflammation, Homocysteine, Oxidative Stress and Antioxidant Capacities (NCT02321579) | Taichung Veterans General Hospital | 2014-12-01 |
| Percutaneous Irreversible Electroportion in Unresectable Liver Cancer Close to Diaphragmatic Dome (NCT02329106) | Fuda Cancer Hospital, Guangzhou | 2014-12-01 |
| Feasibility 3D Perfusion Ultrasound for Liver Cancer SABR Planning and Response Evaluation (NCT02424955) | Stanford University | 2014-11-18 |
| Observational Study of Biomarker During Liver Surgery (NCT02102971) | University of Florida | 2014-10-01 |
| Ipilimumab and Stereotactic Body Radiation Therapy (SBRT) in Advanced Solid Tumors (NCT02239900) | M.D. Anderson Cancer Center | 2014-08-26 |
| 4D Phase Contrast MR: Hypertrophy in Liver Cancer (NCT02618447) | Washington University School of Medicine | 2014-08-05 |
| Ultrasound Guided Thoracic Paravertebral Block for Hepatic Tumors Ablation (NCT02271646) | Mahidol University | 2014-08-01 |
| Treatment of Primary Liver Tumors With Electrochemotherapy (ECT) (NCT02291133) | Masa Bosnjak | 2014-06-01 |